Bcl-1/Cyclin D1 belongs to the G1 cyclins and plays a key role in cell cycle regulation during the G1/S transition by cooperating with cyclin-dependent kinases (CDKs). Its overexpression may lead to growth advantage for tumor cells by way of cell cycle progression, and actually it has been reported in various human cancers, e.g., esophageal, breast, and bladder carcinomas. Among hematolymphoid malignancies, cyclin D1 overexpression resulting from trans-locational activation has also been recognized in a subset of B-chronic lymphocytic leukemia (B-CLL), multiple myeloma, splenic marginal zone lymphoma, hairy cell leukemia, and mantle cell lymphoma. For research purposes only, not for use in diagnostic procedures.
- application:
- IHC, WB
- Catalog number:
- 11011
- clone:
- 5D4
- concentration:
- 200 µg/mL
- Datasheet:
- formulation:
- Lyophilized product from 1% BSA in PBS containing 0.05% NaN3
- immunogen:
- recombinant Human PRAD1/cyclin D1 (E. coli)
- isotype:
- IgG2a
- MSDS:
- notes:
- For research use only, not for use in diagnostic procedures.
The datasheet for this product (see above) is intended to serve as an example only. Please refer to the datasheet provided with the antibody for precise details. - Other names:
- Please see datasheet
- Protocol:
- size:
- 1 mL (500 µg)
- storage:
- Lyophilized 5 years at 2-8°C; liquid form 2 years at -20°C
- Species:
- Human
- Host:
- Mouse
